| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 01/30/2003 | WO2003007924A2 Combinations comprising epothilones and pharmaceutical uses thereof |
| 01/30/2003 | WO2003007917A1 Pharmaceutical formulation comprising a proton pump inhibitor and antacids |
| 01/30/2003 | WO2002056825A3 Composition and method to increase calcium levels in animals |
| 01/30/2003 | WO2002043786A3 Uses for medical devices having a lubricious, nitric oxide-releasing coating for the therapy of vascular disorders |
| 01/30/2003 | WO2002014356A3 Therapeutic use of a recombinant erythropoietin having high activity and reduced side effects |
| 01/30/2003 | WO2002013873A9 P97-active agent conjugates and their methods of use |
| 01/30/2003 | WO2002005795B1 Pharmaceutical combinations for treatment and prevention of diabetes mellitus |
| 01/30/2003 | WO2001091772A3 Compositions for treating eye discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins |
| 01/30/2003 | US20030023088 To produce medicament for therapy and prophylaxis of cancer |
| 01/30/2003 | US20030022923 Methods for treatment of sickle cell anemia |
| 01/30/2003 | US20030022873 Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis |
| 01/30/2003 | US20030022267 Monitoring the physiological effect of a composition on animal; obtain animal, administer moulator, record physiological adjustments |
| 01/30/2003 | US20030022149 Enhanced production of safe plasma preparations |
| 01/30/2003 | US20030022147 Solutions for use as plasma expanders and substitutes |
| 01/30/2003 | US20030021856 New use of ammonium compounds and/or urea |
| 01/30/2003 | US20030021854 Nanocrystal microbiocide metal |
| 01/30/2003 | US20030021811 Modulating production of pneumococcal capsular polysaccharide |
| 01/30/2003 | US20030021786 Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus |
| 01/30/2003 | US20030021751 Supplying high velocity gas under pressure; wound healing agents |
| 01/30/2003 | CA2454043A1 Use of magnesium for preventing in-stent thrombosis and complications after arterial angioplasty with stent placement |
| 01/30/2003 | CA2453290A1 Pharmaceutical formulation comprising a proton pump inhibitor and antacids |
| 01/30/2003 | CA2453108A1 Combinations comprising epothilones and pharmaceutical uses thereof |
| 01/29/2003 | EP1278547A2 Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype |
| 01/29/2003 | EP1024815B1 Pharmaceutical compositions for oral administration of molecular iodine |
| 01/29/2003 | EP0865284B1 Compositions, containing bismuth and one or more antimicrobials, for the prevention and treatment of gastrointestinal disorders |
| 01/29/2003 | CN1393252A Ointment for treating burn and its preparing process |
| 01/29/2003 | CN1393242A Plaster for treating mastoplasia |
| 01/29/2003 | CN1393235A Plaster for treating facial neuritis and its preparing process |
| 01/29/2003 | CN1099883C Tibeten medicine for treating hepatitis B and its preparing process |
| 01/28/2003 | US6511676 Forming cisplatin and ethanol buffered solution; combining with a negatively charged phosphatidyl glycerol lipid deriva-tive; able to reach primary tumors and their metastases after intravenous injection; breast and prostate cancer |
| 01/28/2003 | US6511675 Dietary supplements |
| 01/28/2003 | US6511453 Device for controlled anaesthesia, analgesia and/or sedation |
| 01/28/2003 | CA2284910C Pharmaceutical combined preparations containing erythropoietin and iron preparations |
| 01/24/2003 | WO2002007735A1 Cardiac arrest fluid |
| 01/23/2003 | WO2003006434A1 Metal complexes for use in boron neutron capture therapy |
| 01/23/2003 | WO2003006071A1 Infection control system |
| 01/23/2003 | WO2003006032A1 Pharmaceutical preparations for treatment or prophylaxis of arthritis urica |
| 01/23/2003 | WO2003006031A1 Calcium salts with cytotoxic activity |
| 01/23/2003 | WO2003006005A1 Composition comprising sulfacetamide and a sunscreen for the treatment of rosacea |
| 01/23/2003 | WO2003005988A1 Cosmetic and dermatological preparations containing creatine for treating and actively preventing dry skin and other negative alterations of the physiological homeostasis of healthy skin |
| 01/23/2003 | WO2003005978A1 Remedy against skin diseases |
| 01/23/2003 | WO2003005966A2 Topical medicine and process and apparatus for making same |
| 01/23/2003 | WO2003005955A2 Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus |
| 01/23/2003 | WO2003005941A2 Insert for the treatment of dry eye |
| 01/23/2003 | WO2002053711A3 Use of transcription factor yb-1 in adenoviral systems |
| 01/23/2003 | WO2002044086A3 Sodium zirconium carbonate and zirconium basic carbonate and methods of making the same |
| 01/23/2003 | WO2002043662A3 Dietary composition containing conjugated linoleic acid and calcium for improved health |
| 01/23/2003 | WO2002036127A3 Methods and compositions for the treatment of polycystic ovary syndrome with chromium complexes |
| 01/23/2003 | WO2002003974A3 Composition comprising folic acid and zinc for improving male fertility |
| 01/23/2003 | US20030018371 Compositions and methods for the treatment of metabolic bone disorders and bone metastases |
| 01/23/2003 | US20030018066 Administering vitamin e and selenium, or compound thereof |
| 01/23/2003 | US20030018011 Fatty acid-containing composition |
| 01/23/2003 | US20030017210 Controlled-release for oral administration of cisplatin |
| 01/23/2003 | US20030017188 Administered between 15 and 90 minutes prior to exposure of the subject to thrombogenic stimuli |
| 01/23/2003 | CA2453384A1 Insert for the treatment of dry eye |
| 01/23/2003 | CA2451109A1 Infection control system |
| 01/23/2003 | CA2450898A1 Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus |
| 01/22/2003 | EP1277475A1 Bone-strengthening agents, food compositions for strengthening bone and feed compositions for strengthening bone |
| 01/22/2003 | EP1276697A2 Treatment of fluids |
| 01/22/2003 | EP1276485A2 Compositions useful in the treatment of diseases of connective tissues comprising a ferrous ion and an ascorbate |
| 01/22/2003 | EP1276482A2 Combination chemotherapy |
| 01/22/2003 | EP1276463A1 Hemostatic agent, method and carrier for applying a blood clotting agent |
| 01/22/2003 | EP1276392A2 Nutritional modules |
| 01/22/2003 | EP0937085B1 Magnesium (-)hydroxycitrate, method of preparation, applications, and compositions in particular pharmaceutical containing same |
| 01/22/2003 | EP0728009B1 Use of an agent which modulates tyrosine phosphorylation for modulating the permeability of a psychological barrier |
| 01/22/2003 | CN1391939A External medicine for curing traumatic injuries |
| 01/22/2003 | CN1391930A External medicine for curing gynaecological imflammation and its preparing method |
| 01/22/2003 | CN1391904A Nano hydroxy apatite calcium supplementing agent |
| 01/22/2003 | CN1391903A Microcapsule coated trace element product and its producing method |
| 01/22/2003 | CN1391902A Use of rare-earth nitrate, sulfate, chloride in preparing medicine for curing AIDs |
| 01/22/2003 | CN1391880A Electric moxibustion instrument |
| 01/22/2003 | CN1099288C Pharmaceutical composition for treating inflammtory bowel diseases |
| 01/22/2003 | CN1099283C Slow releasing pill and its preparation |
| 01/21/2003 | US6509326 Supplements are useful for increasing bone growth and treating age-related bone loss |
| 01/16/2003 | WO2003004064A2 Products for treating ovarian cancers and for preventing relapses |
| 01/16/2003 | WO2003004038A1 Topically-applied composition based on ammonium hydroxide |
| 01/16/2003 | WO2003003981A2 Compositions for improving mental performance |
| 01/16/2003 | WO2003003976A2 Compositions for removing human cerumen |
| 01/16/2003 | WO2003003809A2 Methods of using electron active compounds for managing conditions afflicting mammals |
| 01/16/2003 | WO2002085387A3 A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent ans their use in the treatment of inflammatory skin conditions |
| 01/16/2003 | WO2002085386A3 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use to induce apoptosis in cancerous tissue |
| 01/16/2003 | WO2002085385A3 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of diseases of the mucosa |
| 01/16/2003 | WO2002043859A3 Cartridges useful in cleaning dialysis solutions |
| 01/16/2003 | WO2002002094A3 Use of a protein kinase c inhibitor to enhance the clinical efficacy of anti-neoplastic chemotherapeutic agents and radiation therapy |
| 01/16/2003 | WO2001052868A9 Combinations for treating neoplasms |
| 01/16/2003 | WO2001051049A9 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders |
| 01/16/2003 | US20030013771 Concurrent administering with drug; side effect reduction; central nervous system disorders |
| 01/16/2003 | US20030013765 Fluid therapy with l-lactate and/or pyruvate anions |
| 01/16/2003 | US20030013759 Injection fatty acid, or salt thereof, into arteries |
| 01/16/2003 | US20030013739 Synergistic mixtures; side effect reduction |
| 01/16/2003 | US20030013686 Bisphosphonate compound |
| 01/16/2003 | US20030013679 Polymer controlled induced viscosity fiber system and uses thereof |
| 01/16/2003 | US20030013639 Sleep inducing antacid composition |
| 01/16/2003 | US20030012828 Topical medicine and process and apparatus for making same |
| 01/16/2003 | US20030012827 May be administered in a purified form, or as part of a larger molecule, such as a glyceride that may be mixed, which releases free fatty acid after ingestion |
| 01/16/2003 | US20030012826 Carotenoids; vitamins E, D, & C; thiamine; riboflavin; niacin; folic acid; pyridoxine; biotin; pantothenic acid; cobalamin; magnesium; manganese; zinc; selenium; chromium; copper; alpha lipoic acid; and lutein; added iron free |
| 01/16/2003 | US20030012825 Metallized molecule therapies |
| 01/16/2003 | US20030012824 Orally administered anti-stress composition |
| 01/16/2003 | US20030012793 Purified complex of heat shock protein noncovalently bound to a molecule. |
| 01/16/2003 | US20030012783 Interfere with the binding of a tumor necrosis factor receptor with its ligand; inhibiting the proliferation of tumor cells |